Specialty Pharmacy Webinar: Value-Based Management of Multiple Sclerosis

              Gary Rice


More than 400,000 people in the United States and about 2.5 million people in the world have multiple sclerosis. With such widespread impact, there is a great need to study this disease to improve patient care and outcomes. This webinar will provide attendees an in-depth view of this disease state, including its etiology, pathophysiology, clinical presentation, clinical disease courses, disease-modifying therapies, adverse events and mitigation strategies, symptomatic treatment, adherence barriers, pipeline agents, and the role of specialty pharmacy in patient management.

Join Diplomat’s senior vice president of clinical, education and Human Resources, Gary Rice, RPh, MS, MBA, CSP; and Diplomat’s manager of education and training, Stephanie LaPointe, PharmD; as they outline the vital role specialty pharmacy plays in providing quality care for patients affected by multiple sclerosis.

This informative webinar will help you:

  • Understand the pathophysiology, clinical presentation and disease classification schemes of multiple sclerosis
  • Learn about drug therapies used in the treatment of multiple sclerosis, including mechanisms of action, brand/generic names, routes of administration and adverse events
  • Recognize the role of specialty pharmacy in caring for patients affected by multiple sclerosis


The information contained herein may not be construed as medical advice. It is for educational purposes only. Diplomat Pharmacy Inc. takes no responsibility for the accuracy or validity of the information contained herein, nor the claims or statements of any manufacturer.